PDF Return
C. 51
To: Board of Supervisors
From: William Walker, M.D., Health Services Director
Date: February  3, 2015
The Seal of Contra Costa County, CA
Contra
Costa
County
Subject: Thermo Fisher Scientific, Inc. Purchase Order Amendment

APPROVE OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR RECOMMENDATION OF BOARD COMMITTEE

Action of Board On:   02/03/2015
APPROVED AS RECOMMENDED OTHER
Clerks Notes:

VOTE OF SUPERVISORS

AYE:
John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Mary N. Piepho, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor
Contact: Anna Roth, 370-5101
cc: T Scott     C Rucker     Crystal Grayson    
I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED:     February  3, 2015
David Twa,
 
BY: , Deputy

 

RECOMMENDATION(S):

Approve and authorize the Purchasing Agent on behalf of the Health Services Department to execute an amendment to Purchase Order #F51317 with Fisher Scientific, Inc., to add $150,000 for a new total of $450,000, for various clinical and pathology laboratory reagents, small equipment, supplies and test kits for Contra Costa Regional Medical Center (CCRMC) and the Contra Costa Health Centers, with no change in the original term of May 2, 2014 through April 30, 2015.

FISCAL IMPACT:

100% funding is included in Enterprise Fund I Budget.

BACKGROUND:

These reagents, small equipment, supplies, test kits, controls, etc. are used for patient’s specimen testing and are specific to the analyzer used for testing. Among the tests conducted are those for diabetes, kidney function, liver, hepatitis, iron deficiency, cardiovascular disease, cancer, and many others.

CONSEQUENCE OF NEGATIVE ACTION:

If this Purchase Order is not approved the lab will not be able to perform patient testing. This will impact patient safety and care.


CHILDREN'S IMPACT STATEMENT:

No impact.

AgendaQuick©2005 - 2024 Destiny Software Inc., All Rights Reserved